Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
As of today, Abbott(ABT) shares are valued at $109.13. The company's market cap stands at 191.94B, with a P/E ratio of 32.37 and a dividend yield of 2.0%.
During the trading session on 2026-01-22, Abbott(ABT) shares reached a daily high of $121.19 and a low of $105.79. At a current price of $109.13, the stock is +3.2% higher than the low and still -10.0% under the high.
Trading volume for Abbott(ABT) stock has reached 37.1M, versus its average volume of 10.63M.
The stock's 52-week range extends from a low of $105.78 to a high of $141.23.
The stock's 52-week range extends from a low of $105.78 to a high of $141.23.
ABT News
Abbott Laboratories ((ABT)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level d...
Scott Olson/Getty Images Abbott Laboratories ABT -9.73 %decrease; red down pointing triangle said it raised prices across its nutrition business in order to co...
Abbott Laboratories (NYSE:ABT) received CE Mark approval for its TactiFlex Duo ablation catheter for atrial fibrillation in Europe. The company is expanding fu...
Analyst ratings
69%
of 29 ratingsMore ABT News
Abbott (ABT) is down -8.8%, or -$10.66 to $110.07. Claim 50% Off TipRanks Premium Published first on TheFly – the ultimate source for real-time, market-moving...
Image source: The Motley Fool. Thursday, January 22, 2026 at 9:00 a.m. ET Call participants Chairman & Chief Executive Officer — Robert Ford Executive Vice Pre...
Abbott Laboratories (NYSE:ABT) stock fell on Thursday after the company reported fourth-quarter 2025 sales and the first-quarter 2026 earnings outlook below exp...
Stock futures are higher as confidence returns to risk assets and markets rebound sharply from a bout of volatility earlier in the week that saw major indexes p...
Technology Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing Looms Licensing Abbott stock tumbled early Thursday after the health giant reported a...
Abbott (ABT) came out with quarterly earnings of $1.5 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.34 per share a year...
Abbott slumps after reporting sales miss, disappointing Q1 guidance Abbott Laboratories fell in premarket trading after it reported fourth-quarter sales that m...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 companies by market cap and showing a subset from that 100.
Newly Listed
This list is generated by showing companies that recently went public.